Introduction
Psoriasis is a common skin disease and provides a useful model to study the pathogenic significance of chemical mediators of inflammation both in vivo and in vitro. The histological features of this condition include increase epidermal cell proliferation and infiltration of neutrophils, macrophages and lymphocytes into the lesions. In fact, neutrophil infiltrates have been reported to be one of the earliest phenomena in pre-pinpoint lesions [ 11. Elevated levels of leukotriene B, (LTB,) have been reported in extracts of psoriatic skin lesions [Z] , suggesting a pathogenic role for this chemoattractant lipoxygenase product. On the other hand, prostaglandin E, (PGE,) levels in psoriatic skin lesions do not differ significantly from clinically uninvolved skin [3] and are not believed to play a significant pro-inflammatory role in psoriasis. Support for a pathogenic role of LTB, derives in part from studies demonstrating that benoxaprofen, a 5-lipoxygenase (E.C. 1.1 3.1 1.12) inhibitor, causes marked improvement in patients with severe psoriasis [4] . Conversely, specific cyclo-oxygenase (E.C. 1.14.99.1) inhibitors, such as indomethacin, may stimulate the lipoxygenase pathway by diversion of substrate and have been reported to exacerbate the condition [S] . The generation of all arachidonic acid-derived products is inhibited by corticosteroids, which are phospholipase A, inhibitors. However, these drugs have undesirable sideeffects which limit their use. Therefore, the development of non-toxic anti-psoriatic drugs would provide new therapeutic approaches to this disease.
Activation of oxidative metabolism in leucocytes leads to generation of reactive oxidants (RO) in a process designated the respiratory burst [6, 71.
Such production of RO is believed to play a role in the pathogenesis of inflammatory diseases by causing 'auto-oxidative damage' at the site of inflamma- or further metabolism to form hypochlorous acid (HOCI) by myeloperoxidase (MPO). Measurement of chemiluminescence allows quantification of RO production by leucocytes in response to a soluble [9] or particulate [lo] challenge. It also provides a rapid and sensitive method for studying the effect on non-steroidal anti-inflammatory drugs (NSAID) on cell function [ 111. Stimulation of the inflammatory process also leads to the production of leukotrienes [12, 131 including LTB,, which is one of the most potent natural inflammatory mediators known [14, 151. It is understood that the MPO-H,O,-halide system plays an important role in the catabolism of active leukotrienes (C,, D4 and E,) to inactive chiral sulphoxides and diastereoisomers of 6-truns-LTB4 [16] . This effect has been attributed to the action of HOCl produced by leucocytes through the MPO-H,O,-halide system, on the active leukotrienes. LTB, has also been demonstrated to be inactivated by this system, possibly by oxidative cleavage or halogenation [ 171. Such inactivation of LTB, would have a modulatory effect on the inflammatory response and hence the MPO-H,O,-halide system is believed to play an important role in the control of the inflammatory process [18] [19] [20] .
N-2-Hydroxyethylpiperazine-N-2-ethane-sulphonic acid (Hepes) is a substituted taurine derivative and is well known for its properties as a biological buffer [21] . We studied the effect of taurine and Hepes on neutrophil function, using luminol-amplified chemiluminescence in response to calcium ionophore (A23187). We also measured secreted LTB, in the supernatants of A23187-stimulated neutrophils which were preincubated in the presence and absence of taurine or Hepes. Since we showed that neutrophil MPO activity was significantly enhanced in the presence of taurine or Hepes, we describe herein observations in peripheral neutrophils which indicate that taurine and Hepes possess anti-inflammatory properties in vitro, and a hypothesis of the mechanism of action is proposed.
Methods
Peripheral blood from normal subjects, patients with psoriasis and other skin diseases (acne, dermatitis herpetiformis, non-specific and atopic derma-titis) were taken into sodium heparin vacutainers (Becton Dickinson, Rutherford, NJ, U.S.A.) and subjected to dextran sedimentation using Dextraven 150 (Fisons, Loughborough, U.K.), followed by Hypaque-Ficoll gradient centrifugation of the leucocyte-rich plasma (Ficoll-Paque, Pharmacia, Uppsala, Sweden). The neutrophils and residual erythrocytes sedimented to the base of the gradient. Erythrocyte contamination was removed from the neutrophil fraction by hypotonic lysis. Identification and counting of cells was done by fluorescence microscopy using ethidium bromide and Acridine Orange staining. The neutrophils were suspended in 0.9% (w/v) saline containing 1 mwglucose. 
Degranulation, LTB, and PGE,
Degranulation was measured by incubation of 0.5 ml of non-treated, taurine-or Hepes-treated cells at 5 x lo6 cells/ml with 0.5 ml A23187 (2 p~) for 10 min at 37°C. The supernatants were assayed for /3-glucuronidase (E.C. 3.2.1.3.1.) by the fluorimetric method of Peters et al. [22] . LTB, and PGE, levels in the supernatants of stimulated cells were determined by the radioimmunoassay procedures of Salmon etaL [23] and Bauminger etaL [24] , respectively.
DNA, MPO and HOCI
Isolated neutrophils were sonicated and DNA measured by fluorimetry [22] . Sonicated samples were preincubated with either PBS, taurine or Hepes for 1 min at 37°C prior to assay of MPO and HOCl. MPO (E.C. 1.11.17) was assayed spectrophotometrically by the o-dianisidine method [25] .
HOCl was determined by measuring the decrease in absorbance at 290 nm of monochlorodimedon (0.025 mM) using the method of Hager etal. [26] .
Chloramines
Formation of taurine-chloramine and Hepeschloramine was measured by the method of Weiss et al. [27] . The absorption spectra of taurine and hypochlorite (OC1-) and a mixture of taurine and OCI-were determined in a total volume of 1.0 ml PBS, pH 7.3, using a Pye-Unicam SP6-450 spectrophotometer. T o each was then added 10 pl of 1.26 M -H~~~, and the samples were then incubated for 5 min at ambient temperature before re-reading over the same range (230-350 nm).
Statistical analysis
Within each subject group, the effect of taurine or Hepes was assessed statistically using the Wilcoxon signed rank test. For inter-group analysis (normal versus psoriatics and normal versus disease control) the Mann-Whitney U-test for unpaired data was employed. P values < 0.05 were considered to be significant. Table 1 shows that there was a significant reduction in chemiluminecence activity in normal, psoriatic and disease control neutrophils in the presence of taurine or Hepes compared with non-treated cells. There was no significant difference between nontreated, taurine-or Hepes-treated cells in each subject group. Fluorescence microscopy using ethidium bromide and Acridine Orange demonstrated no adverse effect on viability of cells by preincubation with taurine or Hepes.
Results
Extracellular degranulation of the lysosomal enzyme, /3-glucuronidase, was measured in the supernatants of A23 187-stimulated neutrophils from each group. It was demonstrated that there was no significant difference in degranulation by neutrophils preincubated with Hepes compared to non-treated cells. In addition there was no significant difference in degranulation by normal compared with psoriatic cells and disease control cells. It was not possible to assess the effect of taurine on degranulation as it caused a concentration-dependent increase in enzyme activity, which was verified using purified /3-glucuronidase (data not shown). This suggests that this enzyme is unsuitable as a marker of degranulation in studies using taurine.
A significant increase in MPO activity of neutrophils from all subjects in the presence of
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taurine or Hepes was observed. There was no significant difference between non-treated, taurine-or Hepes-treated cells of normal subjects compared to psoriatic or disease control subjects.
A significant increase in HOCl production was noted in each subject group in the Hepestreated neutrophils. In addition, non-treated cells produced greater amounts of HOCl in the psoriatic and disease control groups compared with normal subjects. However, there was no significant difference between the Hepes-treated cells in each subject group. In the presence of taurine there was no observable HOCl production. Further experiments demonstrated no measurable HOCl when hypochlorite was incubated with excess taurine (data not shown). It was concluded that hypochlorite was rapidly sequestered by taurine to form taurinechloramine.
We showed a significant reduction of LTB, levels secreted from taurine-or Hepes-treated cells in each subject group compared with controls in the supernatants of A23 187-stimulated cells. There was no significant difference in secreted LTB, from non-treated normal, psoriatic or disease control cells. In the Hepes-treated samples, while there was no significant difference in LTB, levels by normal and psoriatic cells, a significant difference was observed between normal and disease control samples.
We demonstrated no significant difference in secreted PGE, levels in the supernatants of A23 187-stimulated cells from all subjects treated with taurine or Hepes compared with non-treated cells. We compared the absorption spectrum of taurine-chloramine to that obtained by addition of Hepes to HOCl (Fig. 1) . Fig. l(a) shows that there was no significant absorption of taurine over the range measured, whereas OC1-showed an absorption at 290-300 nm. A mixture of taurine and OCIshowed an absorption at 250-260 nm. This peak was also demonstrated in studies by Weiss et al.
[27] and was attributed to the formation of taurinechloramine. The addition of H,O, reduced OCIwith no effect on taurine-chloramine. Fig. l ( b ) demonstrates no observable absorption of Hepes, whereas there was a significant absorption peak at 250-260 nm in the presence of OC1-, which was also unaffected by the addition of H,Oz.
Discussion
In this study, it was observed that there was a significant reduction in chemiluminescence activity in taurine-or Hepes-treated neutrophils from normal subjects, and patients with psoriasis and other skin diseases compared with non-treated cells (Table 1) .
Thus, a 1 min preincubation at 37°C of non-treated, taurine-or Hepes-treated cells followed by assay of chemiluminescence resulted in a significantly reduced response, suggesting that there was a taurine-or Hepes-dependent reduction of chemiluminescence in all subjects tested.
Stimulation of neutrophils by A23 187 not only activates the respiratory burst, but is also associated with release of granular enzymes from the cells [28] . Our data showing no significant effect of Hepes on degranulation of @-glucuronidase suggested that Hepes did not act as an inhibitor of neutrophil function. Thus, the reduction in chemiluminescence observed in the presence of Hepes was unlikely to have been due to inhibition of the inflammatory response. It was also observed that taurine caused a concentration-dependent increase in B-glucuronidase activity which was confirmed using purified /?-glucuronidase (data not shown). Therefore, degranulation cannot be studied in the presence of taurine using /?-glucuronidase as a marker enzyme. MPO converts H202 to HOCl via a two-step pathway [29]. The first step is the reaction of MPO with H202, where native MPO is converted to Compound I, and the haem group of the enzyme now contains two oxidizing equivalents more than the native enzyme (Fig. 2) totally inhibited by the presence of 1 mM-sodium azide (data not shown). On the other hand, catalase (E.C. 1.1 1.1.6) activity, measured by the method of Peters et al. [22] , was unaffected by the presence of taurine or Hepes (data not shown). Therefore, our results indicated that there was enhanced metabolism of H,O, through the MPO-H,O,-halide system in the presence of taurine or Hepes which might account for the observed reduction in chemiluminescence. However, there was no correlation between enhanced enzyme activity and reduced chemiluminescence response in the presence of taurine or Hepes.
Increased production of HOCl by chlorination of H,Oz was also demonstrated in the presence of Hepes. We were unable to demonstrate HOCl production in the presence of taurine, and believe that sequestration of HOCl by taurine prevented it from being assayed. We believe that taurine-or Hepesmediated manipulation of HOCl production through the MPO-H,O,-halide system could play an important role in the modulating of the inflammatory process.
We showed a significant reduction of LTB, in the supernatants of cells preincubated with taurine or Hepes. The reduced levels of LTB, in these studies were believed to be due to increased catabolism mediated through the MPO-H,O,-halide system. In further studies, we observed that cells preincubated with taurine or Hepes in the presence of 1 mM-potassium iodide showed no measurable LTB, in the supernatants demonstrating an increased susceptibility of active LTB, to hypoiodous acid (data not shown). These observations support the concept that other halide cofactors may be more effective than chloride in this system. Clark & Klebanoff observed this phenomenon in the oxidation of the chemotactic factor C5a and synthetic chemotactic peptide N-formyl-methionylleucyl-phenylalanine [ 181.
It has been observed that neutrophils can transform prostaglandins by the MPO-H,O,-halide system [30] . Our results did not confirm previous reports of PGE, transformation by the MPO-H,O,-halide system. We showed no effect of taurine or Hepes on secreted PGE, by cells from normal, psoriatic or disease control subjects.
Taurine has been proposed to modulate the inflammatory process by scavenging HOCl and is believed to prevent feedback inhibition of HOCl on MPO [31] . Fig. l(a) demonstrates that the chlorination of taurine by OC1-leads to a significant absorption peak at 250 nm which was attributed to the formation of taurine-chloramine [27] . We believe that the absorption peak at 250-260 nm in the presence of Hepes and OC1-was due to the formation of Hepes-chloramine (Fig. 1 b) . S' ince we also demonstrated that taurine-or Hepes-chloramine, as well as HOCl, have the capacity to cause a reduction in LTB, (data not shown), taurine or Hepes would appear to have significant anti-inflammatory properties, i.e. by scavenging HOCl and thereby preventing feedback inhibition of HOCl on MPO. This results in enhanced MPO activity which in turn increases metabolism of RO and also increases further production of HOCl.
The concept of the MPO-H,O,-halide system playing a modulatory role in the control of the inflammatory process is not new, but our studies highlight the significance of stimulating the system by the addition of exogenous taurine or Hepes, and suggest that the metabolic pathway involved could be manipulated to yield reduced levels of inflammatory RO and LTB,. Such control of this pathway would have significant implications in the management of inflammatory diseases. We are currently assessing the effect of other substituted taurine derivatives on RO, HOCl and LTB, production in addition to their effect on MPO. We believe that these studies will give further insight into the natural control of the inflammatory process. We also believe that care of interpretation of results should be taken in studies on the inflammatory response where the 'Good' buffers [21] have been utilized.
It is well recognized that RO and LTB, production by neutrophils are central to the pathogenesis of some inflammatory diseases. We chose psoriasis as a model of cutaneous inflammatory disease, since neutrophils are prominent in its pathogenesis. In this study, we demonstrated that both RO and LTB, levels may be reduced by manipulation of the MPO-H,O,-halide system in vitro by the addition of taurine or Hepes. Therefore, the use of these structurally related compounds may provide new therapeutic strategies for treatment of inflammatory diseases.
